DaShenLin Pharmaceutical Group Co., Ltd.

Shanghai Stock Exchange 603233.SS

DaShenLin Pharmaceutical Group Co., Ltd. Market Capitalization on January 14, 2025: USD 2.12 B

DaShenLin Pharmaceutical Group Co., Ltd. Market Capitalization is USD 2.12 B on January 14, 2025, a -47.24% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

DaShenLin Pharmaceutical Group Co., Ltd. 52-week high Market Capitalization is USD 4.10 B on February 07, 2024, which is 93.24% above the current Market Capitalization.
DaShenLin Pharmaceutical Group Co., Ltd. 52-week low Market Capitalization is USD 1.90 B on July 24, 2024, which is -10.43% below the current Market Capitalization.
DaShenLin Pharmaceutical Group Co., Ltd. average Market Capitalization for the last 52 weeks is USD 2.78 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 603233.SS

DaShenLin Pharmaceutical Group Co., Ltd.

CEO	Mr. Guoqiang Ke
IPO Date	July 31, 2017
Location	China
Headquarters	410 Longxi Avenue
Employees	45,466
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.

Key trends

Past 5 years